PhRMA finds value-based contracts may reduce patient co-pays

PhRMA found that commercially insured patients' co-pays under plans with outcomes-based contracts were 28% lower on average compared with market average, suggesting that value-based contracts may lead

Read the full 279 word article

User Sign In